Stockreport

pSivida Out-licenses EMEA Rights for Durasert™ Three-year Treatment for Posterior Segment Uveitis While Retaining U.S. Commercial Rights; Amended Global Collaboration Agreement with Alimer...

PSIVIDA  (PSDV) 
Last psivida earnings: 2/7 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.psivida.com
PDF WATERTOWN, Mass., July 10, 2017 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug products and technolog [Read more]